Cost-effectiveness of the anti-vascular endothelial growth factor intravitreal injection and panretinal photocoagulation for patients with proliferative diabetic retinopathy in South Korea

被引：0
|
作者：
Hyeon-Jeong Lee
Songhee Cho
Jungeun Park
Yan Jin
Hyung Min Kim
Donghyun Jee
机构：
[1] National Evidence-based Healthcare Collaborating Agency,Division of Healthcare Technology Assessment Research
[2] National Evidence-based Healthcare Collaborating Agency,Patient
[3] Nanjing University of Chinese Medicine,Centered Clinical Research Coordinating Center
[4] Kai Health,Department of Rehabilitation, College of Acupuncture and Moxibustion and Massage Health Preservation and Rehabilitation
[5] St. Vincent’s Hospital,Artificial intelligence
[6] The College of Medicine,Department of Ophthalmology and Visual Science
[7] Catholic University of Korea,undefined
来源：
BMC Health Services Research | / 23卷
关键词：
Anti-VEGF injection; Cost-effectiveness analysis; Panretinal Photocoagulation; Proliferative diabetic retinopathy; South Korea;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Response to First Intravitreal Anti-Vascular Endothelial Growth Factor Injection
    Saurabh, Kumar
    OPHTHALMOLOGICA, 2016, 236 : 48 - 48
  • [32] Intravitreal injection of anti-vascular endothelial growth factor for patients with various retinal diseases
    Kang, Seungbum
    JOURNAL OF THE KOREAN MEDICAL ASSOCIATION, 2016, 59 (01): : 52 - 57
  • [33] EFFICACY OF INTRAVITREAL INJECTION OF ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR AGENTS FOR STAGE 4 RETINOPATHY OF PREMATURITY
    Cheng, Hui-Chen
    Lee, Shui-Mei
    Hsieh, Yi-Ting
    Lin, Po-Kang
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2015, 35 (04): : 660 - 666
  • [34] Combined intravitreal injection of triamcinolone acetonide and panretinal photocoagulation for concomitant diabetic macular edema and proliferative diabetic retinopathy
    Zacks, DN
    Johnson, MW
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2005, 25 (02): : 135 - 140
  • [35] Effect of Intravitreal Bevacizumab on Vascular Endothelial Growth Factor Expression in Patients with Proliferative Diabetic Retinopathy
    Chung, Eun Jee
    Kang, Shin Jeong
    Koo, Ja Seung
    Choi, Yoon Jung
    Grossniklaus, Hans E.
    Koh, Hyoung Jun
    YONSEI MEDICAL JOURNAL, 2011, 52 (01) : 151 - 157
  • [36] Vascular Endothelial Growth Factor in Plasma and Vitreous Fluid of Patients with Proliferative Diabetic Retinopathy Patients after Intravitreal Injection of Bevacizumab
    Ma, Yan
    Zhang, Yan
    Zhao, Tong
    Jiang, Yan-Rong
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2012, 153 (02) : 307 - 313
  • [37] Intravitreal Anti-Vascular Endothelial Growth Factor in Retinopathy of Prematurity: Several Years On
    Lauer, Andreas K.
    ASIA-PACIFIC JOURNAL OF OPHTHALMOLOGY, 2014, 3 (06): : 329 - 330
  • [38] Panretinal photocoagulation versus intravitreal injection retreatment pain in high-risk proliferative diabetic retinopathy
    Farias de Araujo Lucena, Celia Regina
    Ramos Filho, Jose Afonso
    Vieira Messias, Andre Marcio
    da Silva, Jose Aparecido
    Paes de Almeida, Felipe Piacentini
    Scott, Ingrid Ursula
    Santana Ribeiro, Jefferson Augusto
    Jorge, Rodrigo
    ARQUIVOS BRASILEIROS DE OFTALMOLOGIA, 2013, 76 (01) : 18 - 20
  • [39] Intravitreal conbercept injection with panretinal photocoagulation for high-risk proliferative diabetic retinopathy with vitreous hemorrhage
    Xu, Yao
    Ye, Qing
    Shen, Wei
    INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2024, 17 (06) : 1066 - 1072
  • [40] Rationale and Application of the Protocol S Anti-Vascular Endothelial Growth Factor Algorithm for Proliferative Diabetic Retinopathy
    Sun, Jennifer K.
    Glassman, Adam R.
    Beaulieu, Wesley T.
    Stockdale, Cynthia R.
    Bressler, Neil M.
    Flaxel, Christina
    Gross, Jeffrey G.
    Shami, Michel
    Jampol, Lee M.
    OPHTHALMOLOGY, 2019, 126 (01) : 87 - 95
12345